4.8 Article

Kruppel-like Factor 7 engineered for transcriptional activation promotes axon regeneration in the adult corticospinal tract

出版社

NATL ACAD SCIENCES
DOI: 10.1073/pnas.1120684109

关键词

gene therapy; spinal cord injury; adeno associated virus; laser capture microdissection

资金

  1. James and Esther King Biomedical Research Program [JEK09KW-05]
  2. Craig H. Neilsen Foundation
  3. US Army [W81XWH-05-1-0061]
  4. National Institutes of Health [HD057521, NS059866, NEI EY020913, P30-EY014801]
  5. American Health Assistance Foundation
  6. Research to Prevent Blindness
  7. Buoniconti Fund
  8. Walter G. Ross Distinguished Chairs in Developmental Neuroscience
  9. Ophthalmic Research

向作者/读者索取更多资源

Axon regeneration in the central nervous system normally fails, in part because of a developmental decline in the intrinsic ability of CNS projection neurons to extend axons. Members of the KLF family of transcription factors regulate regenerative potential in developing CNS neurons. Expression of one family member, KLF7, is down-regulated developmentally, and overexpression of KLF7 in cortical neurons in vitro promotes axonal growth. To circumvent difficulties in achieving high neuronal expression of exogenous KLF7, we created a chimera with the VP16 transactivation domain, which displayed enhanced neuronal expression compared with the native protein while maintaining transcriptional activation and growth promotion in vitro. Overexpression of VP16-KLF7 overcame the developmental loss of regenerative ability in cortical slice cultures. Adult corticospinal tract (CST) neurons failed to upregulate KLF7 in response to axon injury, and overexpression of VP16-KLF7 in vivo promoted both sprouting and regenerative axon growth in the CST of adult mice. These findings identify a unique means of promoting CST axon regeneration in vivo by reengineering a developmentally down-regulated, growth-promoting transcription factor.

作者

我是这篇论文的作者
点击您的名字以认领此论文并将其添加到您的个人资料中。

评论

主要评分

4.8
评分不足

次要评分

新颖性
-
重要性
-
科学严谨性
-
评价这篇论文

推荐

暂无数据
暂无数据